News

Collaboration with Yale University

Sept 16, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Dianqing (Dan) Wu from Yale University on a series of quantitative proteomics focusing on leveraging our clinical quantitative proteomics assays for biological discoveries.

Read more

Collaboration with Taipei Medical University

Aug 30, 2021 | BALTIMORE –  Complete Omics’ Clinical Genomics team announced a collaboration with Professor Ching-shuen Wang from Taipei Medical University on a series of RNA-seq projects leveraging our DEEPER-SeqS clinical genomics assays for biological discoveries from hard-to-sequence clinical samples.

Read more

Collaboration with Duke University

July 18, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Yiping He from Duke University on a series of grants focusing on leveraging our labeling-dependent large scale quantitative proteomics assays for biological discoveries.

Read more >
Read more

Collaboration with University Medical Center Freiburg

July 16th, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Prof. Dr. Roland Schüle from University Medical Center Freiburg, the teaching hospital of the University of Freiburg.

Read more >
Read more

Collaboration with University of North Carolina

July 15, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Benjamin Vincent from The University of North Carolina, on neoantigen-related projects.

Read more >
Read more

Collaboration with Rutgers Cancer Institute of New Jersey

July 10, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Christian S. Hinrichs from Rutgers Cancer Institute of New Jersey. 

Read more >
Read more

Collaboration with Arvinas Pharmaceuticals

June 25, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Arvinas (Nasdaq:ARVN), a pharmaceutical company inventing the famous proprietary PROTAC® protein degraders.

Read more >
Read more

Collaboration with ErVaccine Technologies

June 20, 2021 | BALTIMORE –  Complete Omics’ announced a collaboration with ErVaccine Technologies, a pharmaceutical company headquartered in Lyon, Rhone-Alpes, Francey, on a neoantigen validation and quantification project.

Read more >
Read more

Collaboration with MANAT BIO, INC.

June 18, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with ManaT Bio on a series of quantitative proteomics focusing on leveraging Complete Omics clinical neoantigen detection and validation platforms, including MANA-SRM (basic research and tissue culture level) and Valid-NEO (clincial tumor tissue level) platforms.

Read more

Collaboration with Dr. Yonghong Wan from McMaster University

June 16, 2021 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Yonghong Wan’s lab at McMaster University at Hamilton Ontario Canada.

Read more >
Read more
Follow by Email
Facebook
Twitter
LinkedIn